Humanized antibodies that recognize beta amyloid peptide

Details for Australian Patent Application No. 2002225921 (hide)

Owner Wyeth Elan Pharma International Limited

Inventors Yednock, Ted; Basi, Guriq; Saldanha, Jose

Agent Spruson & Ferguson

Pub. Number AU-B-2002225921

PCT Pub. Number WO02/46237

Priority 60/251,892 06.12.00 US

Filing date 6 December 2001

Wipo publication date 18 June 2002

Acceptance publication date 10 July 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

Event Publications

6 December 2007 Assignment before Grant

  Neuralab Limited; Wyeth The application has been assigned to Wyeth; Elan Pharma International Limited

10 July 2008 Application Accepted

  Published as AU-B-2002225921

31 July 2008 Corrigenda

  Applications Accepted - Name Index Under the Name Wyeth, Application No. 2002225921, under INID (72), correct the name of the inventor by deleting co-inventor Yednock, Ted

6 November 2008 Standard Patent Sealed

8 April 2010 Alteration of Name

  The name of the patentee has been altered to Elan Pharma International Limited; Wyeth LLC 2003

19 May 2011 Assignment Registered

  Wyeth LLC; Elan Pharma International Limited The patent has been assigned to Wyeth LLC; Janssen Alzheimer Immunotherapy

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002225922

2002225920